Skip to Content

M RE8 (Ropinirole Hydrochloride Extended-Release 8 mg)

Pill with imprint M RE8 is Red, Round and has been identified as Ropinirole Hydrochloride Extended-Release 8 mg. It is supplied by Mylan Pharmaceuticals Inc..

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M RE8

Ropinirole hydrochloride extended-release 8 mg M RE8

Ropinirole Hydrochloride Extended-Release

Imprint
M RE8
Strength
8 mg
Color
Red
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-4093
Inactive Ingredients
lactose anhydrous, ferrosoferric oxide, silicon dioxide, ethylcelluloses, FD&C Red No. 40, FD&C Yellow No. 6, hypromelloses, magnesium stearate, microcrystalline cellulose, propylene glycol, FD&C Blue No. 2

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "M RE8"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.